79 related articles for article (PubMed ID: 7637955)
21. Effect of heparin and aspirin on platelet and clotting activation during leukapheresis.
Fabris F; Casonato A; Randi ML; Belloni M; Quaino V; Ongaro G; Girolami A
Eur J Clin Invest; 1985 Aug; 15(4):188-91. PubMed ID: 2931280
[TBL] [Abstract][Full Text] [Related]
22. Molecular markers of hemostasis activation in nephrotic syndrome.
Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
[TBL] [Abstract][Full Text] [Related]
23. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
[TBL] [Abstract][Full Text] [Related]
24. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
25. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
26. Specificity of fibrinopeptide A (FpA) as a marker for gastrointestinal cancers before and after surgery.
Abbasciano V; Levato F; Zavagli G
Med Oncol Tumor Pharmacother; 1987; 4(2):75-9. PubMed ID: 3669780
[TBL] [Abstract][Full Text] [Related]
27. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
[TBL] [Abstract][Full Text] [Related]
28. Increased coagulation activity of the pleura after tube drainage and quinacrine instillation in malignant pleural effusion.
Agrenius V; Chmielewska J; Widström O; Blombäck M
Eur Respir J; 1991 Oct; 4(9):1135-9. PubMed ID: 1836767
[TBL] [Abstract][Full Text] [Related]
29. Abnormal haemostasis in small cell lung cancer.
Milroy R; Douglas JT; Campbell J; Carter R; Lowe GD; Banham SW
Thorax; 1988 Dec; 43(12):978-81. PubMed ID: 2467397
[TBL] [Abstract][Full Text] [Related]
30. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
31. The immediate effect of aerobic exercise on haemostatic parameters in patients with recently diagnosed mild to moderate essential hypertension.
Lekakis J; Triantafyllidi H; Galea V; Koutroumbi M; Theodoridis T; Komporozos C; Ikonomidis I; Christopoulou-Cokkinou V; Kremastinos DT
J Thromb Thrombolysis; 2008 Apr; 25(2):179-84. PubMed ID: 17551668
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolysis profiles and platelet activation after endothelial cell seeding of prosthetic vascular grafts.
Smyth JV; Welch M; Carr HM; Dodd PD; Eisenberg PR; Walker MG
Ann Vasc Surg; 1995 Nov; 9(6):542-6. PubMed ID: 8746831
[TBL] [Abstract][Full Text] [Related]
33. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
Niewiarowski S
Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
[No Abstract] [Full Text] [Related]
34. Increased intravascular coagulation associated with pregnancy.
Gerbasi FR; Bottoms S; Farag A; Mammen E
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
[TBL] [Abstract][Full Text] [Related]
35. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of fibrinopeptide A in surgery].
Fuwa S
Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
[TBL] [Abstract][Full Text] [Related]
37. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation.
De Sanctis LB; Stefoni S; Cianciolo G; Colì L; Buscaroli A; Feliciangeli G; Borgnino LC; Bonetti M; Gregorini MC; De Giovanni P; Buttazzi R
Int J Artif Organs; 1996 Jul; 19(7):404-10. PubMed ID: 8841854
[TBL] [Abstract][Full Text] [Related]
38. Beta-TG and plasma catecholamines levels after sympathetic stimuli in hypertensives and patients with peripheral vascular disease.
Catalano M; Russo U; Belletti S; Colombo F; Belloni A; del Rosso G; Lombardi F; Libretti A
Thromb Haemost; 1990 Jun; 63(3):383-5. PubMed ID: 2144920
[TBL] [Abstract][Full Text] [Related]
39. [Activity of the coagulation and fibrinolysis in non-insulin-dependent diabetes mellitus. In vivo study].
Conti M; Marongiu F; Mameli G; Mamusa AM; Cambuli AB; Cossu E; Sorano GG; Biondi G; Cirillo R; Balestrieri A
Recenti Prog Med; 1989 Jun; 80(6):297-9. PubMed ID: 2772395
[TBL] [Abstract][Full Text] [Related]
40. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
